[The efficiency of the bactericidal action of serum raised by complement and lysozyme against bacteria which avoid the immunological response of higher organisms].

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Postępy Higieny i Medycyny Doświadczalnej

• Publication date

  2009-10-19

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 19850971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Structure and function of complement protein C1q and its role in the development of autoimmune diseases].

  2009cited by this paper
• Killing of Gram-Negative Bacteria with Normal Human Serum and Normal Bovine Serum: Use of Lysozyme and Complement Proteins in the Death of Salmonella Strains O48

  2009cited by this paper
• Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults

  2008cited by this paper
• Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.

  2008cited by this paper
• The mechanisms of activation of normal human serum complement byEscherichia coli strains with K1 surface antigen

  2008cited by this paper
• A New Family of Lysozyme Inhibitors Contributing to Lysozyme Tolerance in Gram-Negative Bacteria

  2008cited by this paper
• Penetration and saturation of lysozyme in phospholipid bilayers.

  2007cited by this paper
• Staphylococcal complement evasion by various convertase-blocking molecules

  2007cited by this paper
• Opinion paper: Stimulation of complement amplification or activation of the alternative pathway of complement?

  2007cited by this paper
• Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins.

  2007cited by this paper
• Human Pathogenic Borrelia spielmanii sp. nov. Resists Complement-Mediated Killing by Direct Binding of Immune Regulators Factor H and Factor H-Like Protein 1

  2007cited by this paper
• Involvement of complement pathways in patients with bacterial septicemia.

  2007cited by this paper
• Complement evasion of pathogens: common strategies are shared by diverse organisms.

  2007cited by this paper
• Deciphering complement mechanisms: the contributions of structural biology.

  2007cited by this paper
• Structural insights into the innate immune recognition specificities of L‐ and H‐ficolins

  2007cited by this paper
• The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies.

  2007cited by this paper
• Sialic acid utilization by bacterial pathogens.

  2007cited by this paper
• Complement analysis in the 21st century.

  2007cited by this paper
• Mannan‐Binding Lectin in Children with Chronic Gastritis

  2006cited by this paper
• Bactericidal activity of normal bovine serum (NBS) directed against some Enterobacteriaceae with sialic acid-containing lipopolysaccharides (LPS) as a component of cell wall.

  2006cited by this paper
• Structure of C3b reveals conformational changes that underlie complement activity

  2006cited by this paper
• Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.

  2006cited by this paper
• The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance

  2006cited by this paper
• Adsorption of lysozyme to phospholipid and meibomian lipid monolayer films.

  2006cited by this paper
• A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.

  2006cited by this paper
• Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis 1

  2005cited by this paper
• Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.

  2005cited by this paper
• Available carbon source influences the resistance of Neisseria meningitidis against complement

  2005cited by this paper
• Relative Roles of Complement Factor 3 and Mannose-Binding Lectin in Host Defense against Infection

  2005cited by this paper
• Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci1

  2005cited by this paper
• Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.

  2004cited by this paper
• The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.

  2004cited by this paper
• L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement 1

  2004cited by this paper
• Structural and Functional Consequences of Cleavage of Human Secretory and Human Serum Immunoglobulin A1 by Proteinases from Proteusmirabilis and Neisseriameningitidis

  2003cited by this paper
• Amino Acid Sequence Requirements in the Hinge of Human Immunoglobulin A1 (IgA1) for Cleavage by Streptococcal IgA1 Proteases

  2003cited by this paper
• Incorporation of N-Acetylneuraminic Acid into Haemophilus somnus Lipooligosaccharide (LOS): Enhancement of Resistance to Serum and Reduction of LOS Antibody Binding

  2002cited by this paper
• Bacterial strategies for overcoming host innate and adaptive immune responses

  2002cited by this paper
• Ficolins and the lectin complement pathway

  2001cited by this paper
• Mannose‐binding lectin: targeting the microbial world for complement attack and opsonophagocytosis

  2001cited by this paper
• Complement‐mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9

  2001cited by this paper
• Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59).

  2001cited by this paper
• Inactivation of Gram-Negative Bacteria by Lysozyme, Denatured Lysozyme, and Lysozyme-Derived Peptides under High Hydrostatic Pressure

  2001cited by this paper
• Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway1

  2001cited by this paper
• Structure and flexibility of the multiple domain proteins that regulate complement activation

  2001cited by this paper
• The Lipopolysaccharide Structures of Salmonella enterica Serovar Typhimurium and Neisseria gonorrhoeaeDetermine the Attachment of Human Mannose-Binding Lectin to Intact Organisms

  2000cited by this paper
• Pathogenesis of group A streptococcal infections.

  2000cited by this paper
• Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS.

  2000cited by this paper
• Complement activation by Proteus mirabilis negatively charged lipopolysaccharides

  2000cited by this paper
• Role of complement in host defense against bacterial infection.

  1999cited by this paper
• Complement haemolytic activity (classical and alternative pathways), C3, C4 and factor B titres in healthy children

  1999cited by this paper
• Lysozyme association with nucleic acids.

  1999cited by this paper
• Regulation of the complement membrane attack pathway.

  1999cited by this paper
• The non‐enzymatic microbicidal activity of lysozymes

  1999cited by this paper
• Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.

  1999cited by this paper
• Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.

  1999cited by this paper
• A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae

  1998cited by this paper
• Acquired Resistance of Escherichia coli to Complement Lysis by Binding of Glycophosphoinositol-Anchored Protectin (CD59)

  1998cited by this paper
• X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2.

  1998cited by this paper
• Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.

  1998cited by this paper
• Potential virulence factors of Proteus bacilli.

  1997cited by this paper
• Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose

  1997cited by this paper
• Functional characterization of an isogenic meningococcal α-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci

  1997cited by this paper
• Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36

  1996cited by this paper
• Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease.

  1996cited by this paper
• Effect of Vibrio cholerae non-O1 protease on lysozyme, lactoferrin and secretory immunoglobulin A.

  1996cited by this paper
• K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways.

  1994cited by this paper
• Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients

  1992cited by this paper
• The interaction of bacteria with mammalian cells.

  1992cited by this paper
• Redesign of the substrate-binding site of hen egg white lysozyme based on the molecular evolution of C-type lysozymes.

  1992cited by this paper
• Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing

  1992cited by this paper
• Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis.

  1990cited by this paper
• Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data.

  1989cited by this paper
• Serum sensitivity of a Pseudomonas aeruginosa mucoid strain

  1984cited by this paper
• Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

  1983cited by this paper
• Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from salmonella minnesota S218 without causing bacterial death

  1982cited by this paper
• Crystal structure analysis and molecular model of human C3a anaphylatoxin.

  1980cited by this paper
• Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme

  1980cited by this paper
• Crystallographic studies of the dynamic properties of lysozyme

  1979cited by this paper
• Serum Complement Levels in Infancy: Age Related Changes

  1979cited by this paper
• How does lysozyme penetrate through the bacterial outer membrane?

  1976cited by this paper
• Effect of Ethylenediaminetetraacetic Acid, Triton X-100, and Lysozyme on the Morphology and Chemical Composition of Isolated Cell Walls of Escherichia coli

  1971cited by this paper
• Locus of the Action of Serum and the Role of Lysozyme in the Serum Bactericidal Reaction

  1968cited by this paper
• Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants.

  1967cited by this paper

• Age-related variations in the in vitro bactericidal activity of human sera against Pseudomonas aeruginosa

  2018cites this paper
• Transcriptome profiling of Staphylococci-infected cow mammary gland parenchyma

  2017cites this paper
• Effect of histatin-5 and lysozyme on the ability of Streptococcus mutans to form biofilms in in vitro conditions.

  2015cites this paper
• THE EFFECT OF SODIUM BENTONITE SUPPLEMENTATION IN THE DIET OF MINK (Neovison vison) ON THE MICROBIOLOGICAL QUALITY OF FEED AND ANIMAL HEALTH PARAMETERS

  2015cites this paper
• Effects of experimentally increased in ovo lysozyme on egg hatchability, chicks complement activity, and phenotype in a precocial bird.

  2015cites this paper
• [Lysozyme--occurrence in nature, biological properties and possible applications].

  2014cites this paper
• Borrelia burgdorferi sensu lato as activators of the complement system in in vitro model.

  2012cites this paper
• [The role of complement factor H in the pathogenesis of Borrelia infection].

  2012cites this paper
• [Molecular mimicry in the etiology of autoimmune diseases].

  2012cites this paper
• Sub-growth Inhibitory Concentrations of Some Antibiotics Enhance Serum Susceptibility of Escherichia Coli at Elevated Temperature

  2011cites this paper